ArticleJournal of chemical information and modeling2025
Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s.
Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Identifying potential binding sites for complex formation between Tyrosyl-DNA phosphodiesterase 1 and poly [ADP-ribose] polymerase 1.Physical chemistry chemical physics : PCCP · 2026Article
- SHH drives gastric cancer-associated fibroblast activation via ACLY-dependent acetyl-CoA metabolism and histone acetylation.Discover oncology · 2026Article
- Developmentally relevant proteins contribute to chemotherapeutic resistance in neuroblastoma.Frontiers in oncology · 2026Review
- HDAC9 in Insulin Resistance: An Update on Epigenetic Mechanisms, Inflammatory Crosstalk, and Therapeutic Potential.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Myocyte enhancer factor 2 (MEF2) transcription factors regulate several developmental programs, including the control of neural crest development and neuronal differentiation as well as survival. MEF2s are highly expressed in cerebellar granule neurons. Class IIa histone deacetylases (HDACs), abundantly expressed in the brain as well, repress gene expression activity of MEF2 via physical interactions and play a critical role in neuronal apoptosis. In this work, we conducted molecular dynamics (MD) simulation-based investigations to investigate interactions among different class IIa HDACs (HDAC4, HDAC5, HDAC7, and HDAC9) and MEF2s (MEF2A, MEF2B, MEF2C, and MEF2D). Our results show that hydrophobic interactions are the main mechanism for the formation of class IIa HDAC-MEF2 complexes. Our analysis shows that L66 and L67 in all MEF2s mostly contribute to the hydrophobic interactions. All residues that establish hydrophobic interactions, hydrogen bonding, and salt bridges are conserved in all MEF2s. Calculations of the MM/GBSA binding free energies also show that the class IIa HDAC-MEF2 complexes exhibit comparable binding affinities. We performed surface plasmon resonance (SPR)-based direct binding experiments using four different purified class IIa HDACs and MEF2A to validate our computational investigations. The SPR results confirmed the direct binding between the class IIa HDACs and MEF2A with fairly comparable nanomolar affinity (3.5 nM to 19.1 nM). This is a comprehensive study to map interactions among class IIa HDACs and MEF2s. We believe that our investigation offers the scientific community valuable insights to further understand, explore, and investigate biomolecular systems that include the class IIa HDAC-MEF2 complex formations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.